WEST PHARMACEUTICAL SERVICES, INC. Increase (Decrease) in Contract with Customer, Liability
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Increase (Decrease) in Contract with Customer, Liability of -$8.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$16.50M.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $8.50M.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $6.40M.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $1.10M, a 31.25% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $500.00K.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$700.00K.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in contract with customer, liability for fiscal 2019 was $2.50M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$8.00M 10-Q · filed 2026-07-23 | -$1.60M derived: sum of 3 quarters · filed 2026-07-23 | -$500.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $8.50M 10-Q · filed 2026-04-23 | $14.90M derived: sum of 2 quarters · filed 2026-04-23 | $16.00M derived: sum of 3 quarters · filed 2026-04-23 | $14.40M derived: sum of 4 quarters · filed 2026-04-23 |
| 2025-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $7.50M derived: sum of 2 quarters · filed 2026-02-17 | $5.90M derived: sum of 3 quarters · filed 2026-02-17 | $500.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$500.00K derived: sum of 2 quarters · filed 2025-10-23 | -$5.90M 10-Q · filed 2025-10-23 | -$6.50M derived: sum of 4 quarters · filed 2025-10-23 |
| 2025-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | -$7.00M 10-Q · filed 2025-07-24 | -$7.60M derived: sum of 3 quarters · filed 2025-07-24 | -$6.00M derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-31 | -$5.40M 10-Q · filed 2025-04-24 | -$6.00M derived: sum of 2 quarters · filed 2025-04-24 | -$4.40M derived: sum of 3 quarters · filed 2025-04-24 | |
| 2024-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.00M derived: sum of 2 quarters · filed 2025-02-18 | -$700.00K 10-K · filed 2025-02-18 | |
| 2024-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | -$100.00K 10-Q · filed 2024-10-24 | ||
| 2024-06-30 | -$1.70M 10-Q · filed 2024-07-25 | |||
| 2019-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$200.00K derived: sum of 2 quarters · filed 2020-02-24 | $2.50M 10-K · filed 2020-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $2.70M 10-Q · filed 2019-10-29 | ||
| 2019-06-30 | $2.70M 10-Q · filed 2019-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |